Development of 2, 4-diaminoquinazoline derivatives as potent PAK4 inhibitors by the core refinement strategy

In this work, based on a cyclization strategy and structure-guided SAR design, a series of 2,4-diaminoquinazoline derivatives were developed as a new class of PAK4 inhibitors.246